FDA Inspection 1118385 - Aurobindo Pharma Limited - February 21, 2020

FDA Inspection 1118385 for Aurobindo Pharma Limited on February 21, 2020. Classification: Voluntary Action Indicated (VAI).

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 1118385 for Aurobindo Pharma Limited on February 21, 2020. Classification: Voluntary Action Indicated (VAI).

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Aurobindo Pharma Limited

Inspection Date

February 21, 2020

Product Type

Veterinary

Office

Center for Veterinary Medicine

ID: c9b52e8f-bf77-492c-8a49-f01a2f3d34e0

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox